Evidence in Allergy

Our new international study led by researchers at @MacDeptMed @HEI_McMaster @UofT_DoM identifies the most important risk factors for food allergy development, broadening our understanding of preventing food allergies. healthsci.mcmaster.ca/what-drives-fo…

Just published review of 2.8 million participants across 190 studies identifying the risk factors associated with the development of food allergies, published in @JAMAPediatrics. Read here: jamanetwork.com/journals/jamap…

An international study led by researchers with @MacDeptMed have identified the most effective and safest treatments for chronic hives. @dkchu ow.ly/zBQ950WpUgA

Asthma outcomes improve with inhaled corticosteroids plus formoterol, SABA, finds study. Derek Chu (@dkchu), assistant professor @MacDeptMed, spoke with @GoHealio about the findings of the meta-analysis. ow.ly/F4YP50U0yYO

Combining inhaled corticosteroids (ICS) with short-acting beta-agonists (SABA) and combining ICS with formoterol were each associated with lower risks of severe asthma exacerbations, compared to SABA alone. #ACAAI24 ja.ma/3Ysodm2

Do you use topical steroids to manage urticaria? See the evidence in our latest systematic review and meta-analysis, published in @AnnalsAllergy annallergy.org/article/S1081-…

Did you know that Evidence in Allergy is Canada's first @worldallergy Center of Excellence? Our work advances our understanding in allergy, asthma, and clinical immunology

What are the comparative benefits and harms of all the topical and systemic treatments for atopic dermatitis? See @dkchu's recent interview with @GoHealio to learn all the details. healio.com/news/allergy-a…

TODAY IS #WorldAtopicEczemaDay! #AtopicEczema is more than itchy skin, it is a systemic, multidimensional disease that affects the minds & bodies of people around the world - especially youth. globalskin.org/WAED2023 #GlobalSkin #ShareTheBurden #IfYouOnlyKnew

Findings from a recent review on topical therapy options for patients with atopic dermatitis (AD) have important and immediate implications for achieving optimal AD outcomes, says Derek Chu (@dkchu), assistant professor @MacDeptMed ow.ly/Sl8C50PKfrT

Thank you to everyone for sharing their comments and feedback on our draft 2023 #AtopicDermatitis Practice Parameter Update. Read the final guideline soon in @AnnalsAllergy The Joint Task Force on Practice Parameters is sponsored by the @AAAAI_org and @ACAAI

❕RESULTS❕ @dkchu and team compared patient-important outcomes among 68 treatments across 43,123 participants in 219 RCTs. These findings inform optimal #eczema management among patients, caregivers, and clinicians

🚨 Topical treatments are the mainstay for managing #AtopicDermatitis, but with so many options available, how do we choose the best one? Read the new #SystematicReview and network meta-analysis, now published in @jacionline 📄jacionline.org/article/S0091-…

❗RESULTS❗@alexandro_chu and team compared patient-important outcomes among 75 treatments across 28,686 participants in 149 RCTs. These findings inform optimal #eczema management among patients, caregivers, and clinicians

📢NOW PUBLISHED📢 Discover the most effective and safest systemic treatments for #AtopicDermatitis. Read the latest #SystematicReview and network meta-analysis, now available in @jacionline 📃jacionline.org/article/S0091-…

Let’s step back in time to discover the major milestones in #eczema’s history and, perhaps, catch a glimpse of the future. Learn more about eczema's origin story: nationaleczema.org/blog/the-origi… #GetEczemaWise #atopicdermatitis #dermtwitter

We're studying new treatment options for people with tree nut #allergies. Have a tree nut allergy and want to learn more? Contact us: evidenceinallergy.com/contact

#ICYMI Moderate-certainty evidence shows that topical calcineurin inhibitors do not increase cancer risk in patients with #eczema. Our findings support the safe use of tacrolimus and pimecrolimus. @LancetChildAdol thelancet.com/journals/lanch…

#DYK that there are 7 different types of #eczema? Treatment options may vary depending on what type you have and it is important to understand the differences. Take a journey with us to guide you through the 7 types of eczema: allergyasthmanetwork.org/what-is-eczema/

We are partnering with @AAAAI_org & @ACAAI to develop an evidence-based, patient-centered guideline on severe asthma. We are seeking patients & caregivers with lived experience to join our guideline group. If interested, please complete this interest form forms.gle/6nrPeKVsGs9QQM…